Modifications of blood platelet proteins of patients with schizophrenia

By Dietrich-Muszalska Anna   Olas Beata  

Platelets, Vol. 20, Iss. 2, 2009-03 ,pp. : 90-96

Informa Healthcare

Access to resources Recommend Favorite

Platelet Procoagulant Activity Induced In Vivo by Muromonab-CD3 Infusion in Uremic Patients

By Lozano M.   Oppenheimer F.   Cofan F.   Rosinyol L.   Mazzara R.   Escolar G.   Ordinas A.  

Thrombosis Research, Vol. 104, Iss. 6, 2001-12 ,pp. : 405-411

Elsevier

Access to resources Recommend Favorite

Modulation of hematopoiesis by ketanserin in erythropoietin-treated uremic patients: evidence from platelet studies

By Borawski J.   Rydzewski A.   Azzadin A.   Buczko W.   Mysliwiec M.  

Platelets, Vol. 9, Iss. 1, 1998-01 ,pp. : 31-35

Informa Healthcare

Access to resources Recommend Favorite

Erythrocyte glutathione transferase activity: a possible early biomarker for blood toxicity in uremic diabetic patients

By Noce Annalisa   Fabrini Raffaele   Dessì Mariarita   Bocedi Alessio   Santini Silvia   Rovella Valentina   Pastore Anna   Tesauro Manfredi   Bernardini Sergio   Daniele Nicola   Ricci Giorgio  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 219-224

Springer Publishing Company

Access to resources Recommend Favorite

PLATELET AND BLOOD CLOTTING ACTIVATION IN PATIENTS WITH MITRAL VALVE PROLAPSE

By Martini F.   Zuppiroli A.   Gori A.   Chiarantini E.   Fedi S.   Prisco D.   Cellai A.   Boddi V.   Abbate R.   Dolara A.   Gensini G.  

Thrombosis Research, Vol. 83, Iss. 4, 1996-08 ,pp. : 299-306

Elsevier

Access to resources Recommend Favorite